Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ajinomoto Co ( (JP:2802) ) has provided an update.
Ajinomoto Co., Inc. has decided to sell its subsidiary, Ajinomoto Althea, Inc., to Packaging Coordinators Inc. (PCI) as part of its strategic realignment. This move aligns with Ajinomoto’s Medium-Term ASV Initiatives 2030 Roadmap, focusing on high-growth areas and leveraging proprietary technologies to enhance profitability in the healthcare sector.
More about Ajinomoto Co
Ajinomoto Co., Inc. operates in the biopharmaceutical industry, focusing on high value-added services driven by proprietary technologies. The company is known for its AminoScience expertise and is actively pursuing growth in strategic areas with high market potential, including healthcare and gene therapy CDMO services.
YTD Price Performance: 2.52%
Average Trading Volume: 484
Technical Sentiment Signal: Sell
Current Market Cap: $20.42B
For a thorough assessment of 2802 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money